Supernus Pharmaceuticals, Inc. (SUPN)

NASDAQ: SUPN · Real-Time Price · USD

49.53

-0.36 (-0.72%)

Dec 31, 2025, 11:15 AM EST - Market open

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Treatment of Central Nervous System Diseases	661.82M	Log In	Log In	Log In	Log In	Upgrade
Treatment of Central Nervous System Diseases Growth	8.94%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	661.82M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	8.94%	Log In	Log In	Log In	Log In	Upgrade